GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Total Long-Term Assets

Voluntis (XPAR:ALVTX) Total Long-Term Assets : €5.86 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Voluntis's Total Long-Term Assets for the quarter that ended in Jun. 2021 was €5.86 Mil.


Voluntis Total Long-Term Assets Historical Data

The historical data trend for Voluntis's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Total Long-Term Assets Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Total Long-Term Assets
3.07 3.49 3.73 6.63 3.82

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.40 6.63 6.10 3.82 5.86

Voluntis Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.


Voluntis Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Voluntis's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines